130 related articles for article (PubMed ID: 12560567)
1. Glycosylation inhibitors and neuraminidase enhance human immunodeficiency virus type 1 binding and neutralization by mannose-binding lectin.
Hart ML; Saifuddin M; Spear GT
J Gen Virol; 2003 Feb; 84(Pt 2):353-360. PubMed ID: 12560567
[TBL] [Abstract][Full Text] [Related]
2. High mannose glycans and sialic acid on gp120 regulate binding of mannose-binding lectin (MBL) to HIV type 1.
Hart ML; Saifuddin M; Uemura K; Bremer EG; Hooker B; Kawasaki T; Spear GT
AIDS Res Hum Retroviruses; 2002 Nov; 18(17):1311-7. PubMed ID: 12487819
[TBL] [Abstract][Full Text] [Related]
3. Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1.
Pal R; Hoke GM; Sarngadharan MG
Proc Natl Acad Sci U S A; 1989 May; 86(9):3384-8. PubMed ID: 2541446
[TBL] [Abstract][Full Text] [Related]
4. Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1.
Saifuddin M; Hart ML; Gewurz H; Zhang Y; Spear GT
J Gen Virol; 2000 Apr; 81(Pt 4):949-55. PubMed ID: 10725420
[TBL] [Abstract][Full Text] [Related]
5. Mannose binding lectin (MBL) and HIV.
Ji X; Gewurz H; Spear GT
Mol Immunol; 2005 Feb; 42(2):145-52. PubMed ID: 15488604
[TBL] [Abstract][Full Text] [Related]
6. Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization.
Ji X; Olinger GG; Aris S; Chen Y; Gewurz H; Spear GT
J Gen Virol; 2005 Sep; 86(Pt 9):2535-2542. PubMed ID: 16099912
[TBL] [Abstract][Full Text] [Related]
7. Interaction of mannose-binding lectin with HIV type 1 is sufficient for virus opsonization but not neutralization.
Ying H; Ji X; Hart ML; Gupta K; Saifuddin M; Zariffard MR; Spear GT
AIDS Res Hum Retroviruses; 2004 Mar; 20(3):327-35. PubMed ID: 15117456
[TBL] [Abstract][Full Text] [Related]
8. Surfactant protein D binds to human immunodeficiency virus (HIV) envelope protein gp120 and inhibits HIV replication.
Meschi J; Crouch EC; Skolnik P; Yahya K; Holmskov U; Leth-Larsen R; Tornoe I; Tecle T; White MR; Hartshorn KL
J Gen Virol; 2005 Nov; 86(Pt 11):3097-3107. PubMed ID: 16227233
[TBL] [Abstract][Full Text] [Related]
9. Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.
Hoorelbeke B; Huskens D; Férir G; François KO; Takahashi A; Van Laethem K; Schols D; Tanaka H; Balzarini J
Antimicrob Agents Chemother; 2010 Aug; 54(8):3287-301. PubMed ID: 20498311
[TBL] [Abstract][Full Text] [Related]
10. Intracellular mannose binding lectin mediates subcellular trafficking of HIV-1 gp120 in neurons.
Teodorof C; Divakar S; Soontornniyomkij B; Achim CL; Kaul M; Singh KK
Neurobiol Dis; 2014 Sep; 69():54-64. PubMed ID: 24825317
[TBL] [Abstract][Full Text] [Related]
11. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.
Scanlan CN; Pantophlet R; Wormald MR; Ollmann Saphire E; Stanfield R; Wilson IA; Katinger H; Dwek RA; Rudd PM; Burton DR
J Virol; 2002 Jul; 76(14):7306-21. PubMed ID: 12072529
[TBL] [Abstract][Full Text] [Related]
12. N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies.
McCaffrey RA; Saunders C; Hensel M; Stamatatos L
J Virol; 2004 Apr; 78(7):3279-95. PubMed ID: 15016849
[TBL] [Abstract][Full Text] [Related]
13. Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein.
Edwards TG; Hoffman TL; Baribaud F; Wyss S; LaBranche CC; Romano J; Adkinson J; Sharron M; Hoxie JA; Doms RW
J Virol; 2001 Jun; 75(11):5230-9. PubMed ID: 11333905
[TBL] [Abstract][Full Text] [Related]
14. Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein.
Fenouillet E; Gluckman JC
J Gen Virol; 1991 Aug; 72 ( Pt 8)():1919-26. PubMed ID: 1678778
[TBL] [Abstract][Full Text] [Related]
15. Identification of the optimal DC-SIGN binding site on human immunodeficiency virus type 1 gp120.
Hong PW; Nguyen S; Young S; Su SV; Lee B
J Virol; 2007 Aug; 81(15):8325-36. PubMed ID: 17522223
[TBL] [Abstract][Full Text] [Related]
16. Modulation of HIV and SIV neutralization sensitivity by DC-SIGN and mannose-binding lectin.
Marzi A; Mitchell DA; Chaipan C; Fisch T; Doms RW; Carrington M; Desrosiers RC; Pöhlmann S
Virology; 2007 Nov; 368(2):322-30. PubMed ID: 17659761
[TBL] [Abstract][Full Text] [Related]
17. Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition.
Koch M; Pancera M; Kwong PD; Kolchinsky P; Grundner C; Wang L; Hendrickson WA; Sodroski J; Wyatt R
Virology; 2003 Sep; 313(2):387-400. PubMed ID: 12954207
[TBL] [Abstract][Full Text] [Related]
18. The alpha(1,2)-mannosidase I inhibitor 1-deoxymannojirimycin potentiates the antiviral activity of carbohydrate-binding agents against wild-type and mutant HIV-1 strains containing glycan deletions in gp120.
Balzarini J
FEBS Lett; 2007 May; 581(10):2060-4. PubMed ID: 17475258
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
Keller PW; Morrison O; Vassell R; Weiss CD
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875245
[TBL] [Abstract][Full Text] [Related]
20. Construction and phenotypic characterization of HIV type 1 functional envelope clones of subtypes G and F.
Revilla A; Delgado E; Christian EC; Dalrymple J; Vega Y; Carrera C; González-Galeano M; Ocampo A; de Castro RO; Lezaún MJ; Rodríguez R; Mariño A; Ordóñez P; Cilla G; Cisterna R; Santamaría JM; Prieto S; Rakhmanova A; Vinogradova A; Ríos M; Pérez-Álvarez L; Nájera R; Montefiori DC; Seaman MS; Thomson MM
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):889-901. PubMed ID: 21226626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
